The KIR2DS1 positive rate was significantly higher in the HCC group (53.8% vs. 34.9%; odds ratio [OR] 2.18, P = 0.023), the significance of which disappeared in the KIR2DS1/HLA-C2 pair analysis. The gene discussed is C2; the disease is hepatocellular carcinoma.